Press Release_ENHERTU Granted Priority Review in the U.S. for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung Cancer
第一三共在中国已开展了三十年的业务，我们提供的医药产品覆盖各治疗领域.
